Radius Health Total Assets 2010-2019 | RDUS

Radius Health total assets from 2010 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Radius Health Annual Total Assets
(Millions of US $)
2018 $287
2017 $462
2016 $340
2015 $482
2014 $108
2013 $13
2012 $25
2011 $64
2010 $19
2009 $0
Radius Health Quarterly Total Assets
(Millions of US $)
Q3 2019 $227
Q2 2019 $244
Q1 2019 $265
Q4 2018 $287
Q3 2018 $319
Q2 2018 $357
Q1 2018 $404
Q4 2017 $462
Q3 2017 $507
Q2 2017 $239
Q1 2017 $295
Q4 2016 $340
Q3 2016 $378
Q2 2016 $409
Q1 2016 $445
Q4 2015 $482
Q3 2015 $506
Q2 2015 $228
Q1 2015 $247
Q4 2014 $108
Q3 2014 $71
Q2 2014 $81
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q4 2012 $25
Q4 2011 $64
Q4 2010 $19
Q4 2009 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.918B $0.099B
Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius Health Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.419B 39.58
Takeda Pharmaceutical (TAK) Japan $59.257B 10.50
Astellas Pharma (ALPMY) Japan $32.450B 16.21
Eisai (ESALY) Japan $23.257B 44.83
Grifols, S.A (GRFS) Spain $17.395B 22.79
Merck (MKGAF) Germany $17.280B 23.58
Neurocrine Biosciences (NBIX) United States $9.617B 267.18
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.880B 36.54
Ionis Pharmaceuticals (IONS) United States $8.683B 17.59
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.786B 9.94
IPSEN SA ADR (IPSEY) France $6.078B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.263B 16.01
United Therapeutics (UTHR) United States $4.692B 0.00
Evotec AG (EVTCY) Germany $4.257B 68.69
Arrowhead Pharmaceuticals (ARWR) United States $4.059B 75.34
Nektar Therapeutics (NKTR) United States $4.018B 0.00
FibroGen (FGEN) United States $3.987B 117.18
PTC Therapeutics (PTCT) United States $3.658B 0.00
Sage Therapeutics (SAGE) United States $3.577B 0.00
ChemoCentryx (CCXI) United States $2.933B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.774B 11.22
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.239B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.116B 62.59
Xencor (XNCR) United States $2.007B 61.00
Heron Therapeutics (HRTX) United States $1.951B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.870B 22.93
Tilray (TLRY) Canada $1.860B 0.00
Corcept Therapeutics (CORT) United States $1.582B 19.22
USANA Health Sciences (USNA) United States $1.545B 16.15
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.463B 9.98
Theravance Biopharma (TBPH) Cayman Islands $1.436B 0.00
Endo (ENDP) Ireland $1.420B 2.61
Zogenix (ZGNX) United States $1.347B 0.00
Akebia Therapeutics (AKBA) United States $1.153B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.063B 32.93
Portola Pharmaceuticals (PTLA) United States $1.057B 0.00
Karyopharm Therapeutics (KPTI) United States $1.025B 0.00
Dermira (DERM) United States $1.022B 0.00
Aerie Pharmaceuticals (AERI) United States $0.902B 0.00
ImmunoGen (IMGN) United States $0.853B 0.00
Collegium Pharmaceutical (COLL) United States $0.801B 0.00
TherapeuticsMD (TXMD) United States $0.651B 0.00
Flexion Therapeutics (FLXN) United States $0.621B 0.00
Molecular Templates (MTEM) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Ardelyx (ARDX) United States $0.545B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.530B 64.25
Translate Bio (TBIO) United States $0.481B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.475B 20.47
Organogenesis Holdings (ORGO) United States $0.465B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.455B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Calithera Biosciences (CALA) United States $0.419B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.417B 0.00
Siga Technologies (SIGA) United States $0.405B 9.26
DURECT (DRRX) United States $0.396B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.387B 0.00
Recro Pharma (REPH) United States $0.385B 0.00
Lannett Co Inc (LCI) United States $0.374B 6.03
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.369B 0.00
Indivior (INVVY) United States $0.359B 2.13
Concert Pharmaceuticals (CNCE) United States $0.346B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.324B 0.00
Rafael Holdings (RFL) United States $0.324B 0.00
OptiNose (OPTN) United States $0.316B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.296B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.267B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.262B 0.00
KalVista Pharmaceuticals (KALV) United States $0.259B 0.00
Ocular Therapeutix (OCUL) United States $0.254B 0.00
MEI Pharma (MEIP) United States $0.249B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.226B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.210B 0.00
Nature's Sunshine Products (NATR) United States $0.198B 34.10
Jounce Therapeutics (JNCE) United States $0.195B 2.60
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
Xeris Pharmaceuticals (XERS) United States $0.127B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.123B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.119B 0.00
CannTrust Holdings (CTST) Canada $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Otonomy (OTIC) United States $0.113B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.111B 0.00
Redhill Biopharma (RDHL) Israel $0.110B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
CV Sciences (CVSI) United States $0.085B 0.00
Champions Oncology (CSBR) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
CTI BioPharma (CTIC) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.32
SCYNEXIS (SCYX) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
IsoRay (ISR) United States $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
Natural Alternatives (NAII) United States $0.051B 23.28
Forward Pharma (FWP) Denmark $0.050B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.050B 0.00
VAXART, INC (VXRT) United States $0.050B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
PolarityTE (PTE) United States $0.044B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
Biomerica (BMRA) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Vical (BBI) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cardiome Pharma (CORV) Canada $0.016B 0.00
Shineco (TYHT) China $0.015B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00